THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
47 hedge funds and large institutions have $165M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
47
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.96M | |
| 2 | +$1.57M | |
| 3 | +$1.39M | |
| 4 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$1.25M |
| 5 |
O
OrbiMed
New York
|
+$956K |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$2.38M | |
| 3 | -$1.29M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$337K |